North America Biobanking Market share, Size, Analysis, Growth & Report | 2025-2034

The North America biobanking market size was valued at USD 1.1 billion in 2024, driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region. The market is expected to grow at a CAGR of 6.31% during the forecast period of 2025-2034, with the values likely to rise from USD 1.2 billion in 2025 to USD 2 billion by 2034. Biobanks are essential for collecting, storing, and managing biological samples, which are crucial for advancing research and development in healthcare, genomics, and pharmaceuticals.

As healthcare continues to evolve and the need for precision medicine and personalized treatments grows, biobanks are becoming increasingly important in North America. The North American biobanking market, shedding light on its key drivers, trends, segmentation, growth prospects, and market dynamics.

Get a Free Sample Report with a Table of Contents: https://tinyurl.com/28hnwhvs

North America Biobanking Market Overview

Biobanks serve as critical resources for the medical, pharmaceutical, and biotechnology industries. They store biological materials such as blood, tissue, and DNA samples, which are invaluable for conducting research in disease pathology, drug discovery, and personalized medicine. The North American biobanking market has been gaining momentum due to increased investments in healthcare research, the rise in chronic diseases, and advancements in genomics. North America, particularly the United States and Canada, is home to numerous research institutions, universities, and healthcare organizations, contributing to the steady growth of the biobanking sector.

The demand for biobanks is largely driven by the need to understand complex diseases, identify genetic markers, and develop targeted therapies. Moreover, biobanks play a critical role in the discovery of new treatments and vaccines, which is particularly relevant in the context of global health concerns. As North America invests in precision medicine, the reliance on biobanks will continue to rise, creating new opportunities for growth and innovation in the market.

North America Biobanking Market Dynamics

Drivers

Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is a major factor driving the biobanking market. Biological samples are essential for understanding the genetic and environmental factors contributing to these diseases, enabling the development of effective treatments.

Growing Demand for Personalized Medicine: Precision medicine, which tailors treatments based on individual genetic profiles, is gaining popularity. Biobanks play a critical role in advancing personalized medicine by providing the biological data necessary for drug development and the identification of genetic biomarkers.

Advancements in Genomic Research: Rapid advancements in genomic technologies, such as CRISPR gene editing and next-generation sequencing, have accelerated the demand for biological samples. Biobanks store these samples, enabling researchers to conduct large-scale genomic studies and identify novel therapeutic targets.

Supportive Government Policies: Governments in North America, especially in the United States, are supporting biobanking through funding, grants, and research incentives. The National Institutes of Health (NIH) and other federal agencies are continuously investing in biobank initiatives, facilitating the expansion of biobanks in the region.

Rising Investments in Healthcare Research: The North American market benefits from robust investments in healthcare research. Public and private institutions are increasingly funding biobank infrastructure, which is fostering the growth of biobanks across the region.

Read Full Report with Table of Contents: https://tinyurl.com/2yvuuau8

Restraints

Ethical and Legal Concerns: The collection and storage of biological samples raise ethical and legal concerns related to privacy, consent, and ownership of samples. These concerns may hinder the growth of the biobanking sector, particularly if stringent regulations are enforced.

High Operational Costs: Setting up and maintaining a biobank requires significant investment in infrastructure, equipment, and trained personnel. The high operational costs can be a challenge for smaller biobank operations and may slow down the expansion of the market.

Sample Contamination and Storage Issues: Biobanks face the risk of sample degradation and contamination, which can compromise the quality of stored samples. The need for proper storage conditions and regular monitoring adds to the operational costs and challenges faced by biobanks.

External North America Biobanking Market Trends

Shift Towards Digital Biobanking: As the demand for data-driven research increases, digital biobanking is becoming a key trend. The use of digital technologies for sample tracking, data management, and analysis is improving the efficiency and accessibility of biobank resources.

Integration of Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are being integrated into biobanks to improve data analysis and sample processing. These technologies help researchers quickly analyze vast amounts of biological data, making the research process more efficient and accurate.

Collaborations and Partnerships: The North American biobanking market is witnessing an increase in collaborations between biobank operators, research institutions, pharmaceutical companies, and healthcare providers. These partnerships enable resource sharing, data pooling, and joint research initiatives, fostering innovation in the sector.

Focus on Rare Disease Research: There is growing interest in the use of biobanks for rare disease research. Biobanks are becoming crucial for gathering rare biological samples that can help researchers identify new treatment pathways for conditions with limited treatment options.

Sustainability Efforts: With growing awareness around environmental sustainability, many biobanks are adopting eco-friendly practices. This includes the use of renewable energy sources, reducing waste, and minimizing the carbon footprint of biobank operations.

North America Biobanking Market Segmentation

The North America biobanking market is segmented based on several factors, including product type, application, and region. Let's look at the key segments:

1. By Product Type

Human Biobanks: This segment includes the collection of human tissues, blood, and genetic samples for research purposes. Human biobanks are extensively used in genetic research, drug discovery, and personalized medicine.

Animal Biobanks: Animal biobanks store biological materials from animals, which are crucial for research in fields such as veterinary medicine, toxicology, and drug development.

Plant Biobanks: These biobanks focus on storing plant genetic resources, which are important for agricultural research, biodiversity conservation, and crop improvement.

2. By Application

Genomics Research: Genomic research is one of the primary applications of biobanks. Researchers use samples stored in biobanks to study the genetic makeup of individuals and identify disease markers.

Drug Discovery and Development: Biobanks play a key role in drug discovery by providing biological samples for screening and identifying potential drug targets.

Personalized Medicine: As personalized medicine continues to grow, biobanks are essential for providing the genetic data necessary to tailor treatments to individual patients.

Disease Research: Biobanks are crucial for studying the genetic and environmental factors involved in the development of diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders.

3. By Region

United States: The U.S. is the largest market for biobanking in North America, with a large number of biobanks operating across the country. Government funding, a well-established healthcare infrastructure, and a strong presence of pharmaceutical companies make the U.S. the dominant player in the biobanking market.

Canada: Canada is also witnessing significant growth in the biobanking sector, with several research institutions and universities leading the way in biobank development. The Canadian government's support for healthcare research is helping boost the market.

North America Biobanking Market Growth

The North American biobanking market is expected to experience steady growth due to increasing demand for precision medicine, advancements in genomic research, and growing investments in healthcare research. The market is poised to benefit from the rising prevalence of chronic diseases and the need for more effective treatment options.

Moreover, the ongoing advancements in biotechnology and the integration of AI and machine learning into biobank operations are expected to drive innovation and efficiency in the sector. Biobanks will continue to play a vital role in enabling researchers to develop new therapies and vaccines, contributing to the growth of the market.

Recent North America Biobanking Market Developments

Recent developments in the North American biobanking market include the establishment of large-scale biobank initiatives, with several research institutions in the U.S. and Canada expanding their biobank resources. Partnerships between biobanks, pharmaceutical companies, and universities are also increasing, fostering collaboration and data sharing for drug discovery and disease research.

Furthermore, digital biobanking is gaining traction, with companies investing in technologies that allow for better sample tracking, data management, and analysis. The integration of AI and ML is improving the efficiency of biobank operations, allowing for faster and more accurate research outcomes.

North America Biobanking Market Scope

The North America biobanking market has significant scope for growth, driven by the increasing demand for personalized medicine, advancements in genomic technologies, and the rising prevalence of chronic diseases. With robust government support, well-established healthcare infrastructure, and a growing focus on research and development, North America is expected to remain the largest market for biobanks in the coming years.

The scope of the market extends beyond the collection and storage of biological samples to include data management, bioinformatics, and the integration of digital technologies to enhance research capabilities. As the market continues to evolve, biobanks will play an increasingly important role in advancing healthcare research and drug discovery.

North America Biobanking Market Analysis

The North American biobanking market is set for steady growth, driven by technological advancements, increasing investments in healthcare research, and the rising demand for precision medicine. The market benefits from a strong ecosystem of research institutions, government funding, and collaborations with pharmaceutical companies. The ongoing shift towards digital biobanking and the adoption of AI technologies will further enhance the market's growth prospects.

The biobanking market is also expected to see an increase in the use of biobanks for rare disease research, as well as the growing need for sustainable practices in biobank operations.

COVID-19 Impact Analysis

The COVID-19 pandemic had a profound impact on the North American biobanking market. While research activities were temporarily disrupted, the pandemic highlighted the importance of biobanks in supporting healthcare research, particularly in the development of vaccines and treatments for infectious diseases. The demand for biological samples for COVID-19 research led to increased funding and investments in biobank infrastructure.

The pandemic also accelerated the adoption of digital technologies in biobanking, as remote data management and sample tracking became essential. As the world recovers from the pandemic, biobanks are expected to play an even more significant role in global healthcare research and disease prevention.

Key Players in the North America Biobanking Market

Atlanta Biologicals Inc. (Bio-Techne Corporation): Based in the U.S., Atlanta Biologicals provides high-quality biological materials and reagents for research and clinical applications. The company is a major player in the biobanking sector, supporting genomics research and drug discovery.

Becton, Dickinson and Company: Becton Dickinson is a leading provider of medical devices, laboratory equipment, and reagents. The company plays a significant role in the biobanking market by offering solutions for sample collection, storage, and analysis.

BioLifeSolution Inc.: Based in the U.S., BioLifeSolution provides biopreservation media, cryopreservation, and sample storage solutions. The company is a key player in the biobanking industry, offering products that support the safe storage and transport of biological samples.

(FAQ)

1. What is biobanking?

Biobanking is the process of collecting, storing, and managing biological samples, such as blood, tissues, and DNA, for research purposes.

2. What are the applications of biobanks?

Biobanks are used for genomics research, drug discovery, personalized medicine, and disease research, helping advance medical knowledge and therapies.

3. How is the North American biobanking market growing?

The market is growing due to rising demand for precision medicine, advancements in genomics, and increasing investments in healthcare research.

4. What are the challenges in the biobanking market?

Challenges include ethical concerns, high operational costs, and sample contamination risks, which need to be addressed to ensure market growth.

5. Who are the key players in the North American biobanking market?

Key players include Atlanta Biologicals Inc. (Bio-Techne Corporation), Becton, Dickinson and Company, and BioLifeSolution Inc.

Related trending market reports:

Global IoT Medical Devices Market: https://tinyurl.com/2chfn988
Global Health and Wellness Market: https://tinyurl.com/25hkhwgy
Global Computational Biology Market: https://tinyurl.com/244rxu56
Global Telepsychiatry Market: https://tinyurl.com/28fk9y8v

Media Contact:

Company Name: Claight Corporation
Contact Person: Dhruv, Corporate Sales Specialist - U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
Aus Site: https://www.expertmarketresearch.com.au

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.